Results 51 to 60 of about 96,164 (192)
Journal of Lipid Research, 2018 Obesity and its associated metabolic dysfunction and cardiovascular disease risk represent a leading cause of adult morbidity worldwide. Currently available pharmacological therapies for obesity have had limited success in reversing existing obesity and ...
Amy C. Burke +7 more
doaj +1 more source
Alcoholic Liver Disease: A Comprehensive Review [PDF]
European Medical Journal, 2016 Alcoholic liver disease, a leading cause of morbidity, mortality, and cirrhosis, can range from simple steatosis to hepatocellular carcinoma. Multiple mechanisms such as oxidative stress, mitochondrial dysfunction, and alteration in gut-liver axis have ...
Partha Pal, Sayantan Ray
doaj
СКРИНИНГОВЫЕ МЕТОДЫ ВЫЯВЛЕНИЯ ФИБРОЗА ПЕЧЕНИ
Архивъ внутренней медицины, 2012 The article presents current data on the diagnosis methods of liver diseases. Recommendations on the management of patients with pathology of the hepatic system on the detection of disease are given.
С. С. Вялов
doaj +1 more source
Lipids in Health and Disease, 2011 Background Peroxisome proliferator activated receptor alpha (PPARα) regulates lipids metabolism and inhibits inflammatory response. However, the role of PPARα in alcoholic liver disease is largely unknown. We aim to elucidate the effect and the molecular
Kong Lingbo +9 more
doaj +1 more source
Терапевтический архивIn September 2023, the European Association for the Study of the Liver (EASL) updated the disease nomenclature for non-alcoholic (metabolically associated) fatty liver disease.
Chavdar S. Pavlov +9 more
doaj +1 more source
Hepatic Macrophages Express Melanoma Differentiation-Associated Gene 5 in Nonalcoholic Steatohepatitis [PDF]
, 2021 Shogo Kawaguchi +12 more
openalex +1 more source
Journal of Education, Health and Sport, 2017 High-fat diets combined with the introduction of lincomycin causes the development of steatohepatitis. Introduction antidysbiotic drugs (pro- and prebiotics) has a therapeutic effect.
A. P. Levitsky +2 more
doaj